Genzyme Corporation drugs
14 results
Aldurazyme (laronidase)
(laronidase)Genzyme Corporation
Usage: ALDURAZYME® is indicated for treating adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I), and for those with moderate to severe symptoms of the Scheie form. Its safety and effectiveness in mildly affected Scheie patients and CNS effects are not established.
Aubagio (teriflunomide)
(teriflunomide)Genzyme Corporation
Usage: AUBAGIO® is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease.
Cablivi (caplacizumab)
(caplacizumab)Genzyme Corporation
Usage: CABLIVI is indicated for treating adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) as part of a combination therapy that includes plasma exchange and immunosuppressive treatment.
Caprelsa (vandetanib)
(Vandetanib)Genzyme Corporation
Usage: CAPRELSA is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease. It may be used in cases of indolent, asymptomatic, or slowly progressing disease after careful consideration of potential treatment risks.
Caprelsa (vandetanib)
(Vandetanib)Genzyme Corporation
Cerdelga (eliglustat)
(eliglustat)Genzyme Corporation
Usage: CERDELGA is indicated for the long-term treatment of adults with Gaucher disease type 1 (GD1) who are CYP2D6 extensive, intermediate, or poor metabolizers. It is not recommended for ultra-rapid metabolizers or patients with indeterminate CYP2D6 genotypes due to potential inadequate therapeutic effect.
Cerezyme (imiglucerase)
(IMIGLUCERASE)Genzyme Corporation
Usage: Cerezyme is indicated for the treatment of adults and pediatric patients aged 2 years and older with Type 1 Gaucher disease, addressing conditions such as anemia, thrombocytopenia, bone disease, and hepatomegaly or splenomegaly.
Fabrazyme (agalsidase beta)
(AGALSIDASE BETA)Genzyme Corporation
Usage: FABRAZYME® is indicated for treating adult and pediatric patients aged 2 years and older with confirmed Fabry disease.
Hectorol (doxercalciferol)
(DOXERCALCIFEROL)Genzyme Corporation
Usage: HECTOROL is indicated for treating secondary hyperparathyroidism in adult patients with Stage 3 or 4 chronic kidney disease (CKD) and those on dialysis. It is available in both capsule and injection forms for this purpose.
Lemtrada (alemtuzumab)
(ALEMTUZUMAB)Genzyme Corporation
Usage: LEMTRADA is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including relapsing-remitting and active secondary progressive MS. It is recommended for patients who have not responded adequately to two or more MS treatments. It is not recommended for clinically isolated syndrome (CIS).